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Background/aim: Colorectal adenomatous polyps are precursors of colorectal cancer (CRC), which can be prevented with surveillance
colonoscopy. This study aimed to assess risk factors for the recurrence of colorectal polyps and CRC following polypectomy.
Materials and methods: In this single-center trial, a total of 510 patients who applied to the endoscopy unit of Hacettepe University
Hospital for various reasons and who were diagnosed with at least one colorectal adenomatous polyp between 2000 and 2010 were
retrospectively analyzed. Patients with colorectal adenomatous polyps or CRC recurrences were examined in terms of clinical and
histological risk factors.
Results: A total of 190 (37.1%) patients had surveillance colonoscopy. Among them, 127 (66.3%) were found to have polyp recurrence.
Of the parameters defined for polyp recurrence, no association was found between the number of polyps (1–2, ≥3) (1–3, ≥4) in the first
colonoscopy and diabetes mellitus, hypertension, hyperlipidemia, sex, family history of colon malignancy, smoking, alcohol usage, size of
polyp (<10 mm, ≥10 mm), or advanced histologic type of polyp. The only significant difference was observed in patients who had left-sided
colon polyps. In the basal colonoscopy, 130 patients had been diagnosed with CRC, and a significant correlation was found between the
number of polyps (1, ≥2) and polyp size (≥10 mm), anemia, high sedimentation rate (>25), and CRC. In the first surveillance colonoscopy,
CRC was detected in 12 patients. There was a significant correlation between the development of CRC and advanced histological type,
anemia with high erythrocyte sedimentation rate, polyp size (<10 mm, ≥10 mm), and the number of polyps (<3, ≥3).
Conclusion: Patients with left-sided colon polyps had a high risk of developing colorectal polyp recurrence. Moreover, the risk of
developing CRC increased in patients who had advanced histology, a polyp larger than 10 mm, or more than three polyps.
Key words: Colorectal adenomatous polyps, recurrence, colorectal cancer

1. Introduction
Neoplastic colorectal polyps include adenomatous polyps
and carcinomas. Nonneoplastic colorectal polyps include
hyperplastic, hamartomatous, and inflammatory polyps.
Although colorectal polyps are usually asymptomatic due
their hidden growth pattern, they may also be present
with ulceration and bleeding. They are most frequently
found during endoscopic or radiologic imaging studies.
Colorectal polyps are precursors of colorectal cancer
(CRC), and removing these polyps has been shown to
reduce the risk of developing CRC (1,2). To further
minimize the risk of CRC, patients with adenomatous
polyps are usually placed in a surveillance program of
periodic colonoscopy to remove missed synchronous
or new metachronous adenomas and cancers (3). The
risk of a polyp developing into a cancer is variably
determined by a number of criteria, such as the size and
number of detected polyps, the histological type (villous
* Correspondence: dr.ozturkates@yahoo.com
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or tubular), morphology (sessile or polypoid), and degree
of dysplasia. Characteristics of the baseline colonoscopy
are also an important predictor for developing subsequent
neoplasia and determining appropriate intervals for
postpolypectomy surveillance. Several recent studies
have suggested that basal colonoscopy findings stratify
adenomas into low- or high-risk (i.e. adenoma ≥10 mm,
villous adenoma, adenoma with high-grade dysplasia, or
invasive cancer) groups for recurrent adenomas during
surveillance colonoscopy (3,4). CRC arises from both
genetic and environmental factors and their interaction.
Genetic predisposition is the dominant risk factor for some
individuals; however, environmental factors (including
diet, exercise, smoking, and obesity) are stronger risk
factors for most people (5). Most cases of CRC occur in
patients with average risk who have no family or medical
history of cancer predisposition. Since increasing age
and male sex are associated with an increased incidence

ATEŞ et al. / Turk J Med Sci
of CRC, current guidelines recommend that screening
should start after 50 years of age even if risk factors are
absent (6). This study aimed to assess the risk factors for
the recurrence of colorectal polyps and CRC following
polypectomy.
2. Materials and methods
A total of 600 patients over the age of 18 who were admitted
to the endoscopy unit of the gastroenterology department
of Hacettepe University Hospital for various reasons
and who were diagnosed with at least one colorectal
adenomatous polyp between 2000 and 2010 were
retrospectively analyzed. We excluded 90 patients who
had inflammatory bowel disease, familial adenomatous
polyposis, or missing information. The demographic
characteristics of the patients, their habits, the drugs that
they used, their comorbid diseases, and their symptoms
during the diagnostic course were analyzed. Colonoscopy
findings and the histological characteristics of the polyps
were also recorded. The total number of polyps, their
size, and the location of each polyp were also recorded.
Adenomas were classified as follows: tubular, tubulovillous,
villous, and serrated adenomas. Polyps larger than 10 mm,
three or more adenomatous polyps, and significant villous
component were defined as advanced polyps. Polyps larger
than 5 mm were removed by standard snare excision and
those smaller than 5 mm were removed by biopsy forceps.
Ethics committee approval was obtained prior to
study initiation. Patients who had polyp recurrences
were examined for risk factors such as comorbid disease,
pathologic features, size, and number of polyps.
2.1. Statistical analysis
Data were analyzed using SPSS 15.0 (SPSS Inc., Chicago, IL,
USA). The histological findings of the polyps and clinical
characteristics of the patients were analyzed by descriptive
statistics (mean, median, percentage, standard deviation,
and minimum and maximum values). In the comparison
between continuous variables of the two groups, either
Student’s t-test or the Mann–Whitney U test was used.
Fisher’s exact test or the chi-square test was used for
analysis of categorical variables. Risk factors were analyzed
with chi-square analysis. Odds rates were calculated with
logistic regression. All tests of significance were two-tailed,
and P < 0.05 was considered as statistically significant.
3. Results
A total of 510 patients were enrolled in the study. Of the
510 patients, 354 (69.4%) were men. The median age was
64 years old (range: 30–96), with 63.5% of the patients
being older than 60 years old (Table 1). A total of 869
polyps (median: 1; range: 1–9) were established in the fir
basal st colonoscopy. The number of polyps detected in the
basal colonoscopy was one and two in 62.2% and 21.2%

of the patients, respectively. Most polyps were smaller
than 10 mm (54.5%), with a mean size of 11.4 ± 13 mm
(range: 1–80 mm). Of the polyps detected in the basal
colonoscopy, 68.1% were left-sided (rectum, sigmoid and
descending colon) and 31.9% were right-sided (cecum,
ascending and transverse colons). Comorbid diseases
and the medication history of all patients are shown in
Table 1. Gastrointestinal (GIS) hemorrhage was the most
common indication for performing colonoscopy (32%).
Adenomatous and tubular changes were observed in
293 (33.7%) and 154 (17.7%) of all polyps, respectively.
Anemia was found in 220 (43.1%) patients, with a mean
hemoglobin value of 12.9 ± 2.2 g/dL (range: 5.4–18.9 g/
dL). The erythrocyte sedimentation rate (ESR) could be
monitored in 235 patients, with a mean value of 25.1 ± 26
mm/h (range: 1–140).
Of the patients, 190 (37.1%) had surveillance
colonoscopy. Among them, 127 (66.3%) were found to
have polyp recurrence (total of 196 polyps and a median
of 1 (range: 1–8) polyp). Median time to first surveillance
colonoscopy was 11 (range: 1–152) months. According to
polyp features, 126 of 190 patients were in the high-risk
group. The recurrence rate of polyps for the first, second,
and third year was 76 (40%), 104 (55%), and 114 (58.7%),
respectively. Of the parameters defined for recurrence,
no association was found between the number of polyps
in the basal colonoscopy (1–2, ≥3) (1–3, ≥4), diabetes
mellitus (DM), hypertension (HT), hyperlipidemia (HL),
sex, family history of colon malignancy, smoking, alcohol
use, size (<10 mm, ≥10 mm), and advanced histologic type
(Tables 2 and 3). There was a significant difference between
adenomatous polyp recurrence and left-sided polyps (P =
0.02) (Table 2).
In the basal evaluation colonoscopy, 130 patients had
been diagnosed with CRC and significant correlations
were found between the number of polyps (1, ≥2) and the
size of the polyp (≥10 mm), anemia, high sedimentation
rate (>25 mm/h), carcinoembryonic antigen (CEA)
(>4 ng/mL), and CRC (Table 4). In the first surveillance
colonoscopy, CRC was found in 12 patients, five of whom
had an advanced histological type of CRC. There was a
significant correlation between the development of CRC
and advanced histological type (OR = 5 (1.3–18.0); P =
0.02), anemia with high ESR, polyp size (<10 mm, ≥10
mm), and the number of polyps (<3, ≥3).
4. Discussion
CRC is the third most common type of cancer worldwide
(7). In Turkey, CRC is the fourth most common cancer
type in men and the third most common type in women.
As many as 95% of all CRCs develop from adenomatous
polyps (8). CRC can be prevented with surveillance
colonoscopy (9). According to colonoscopy series, the
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Table 1. Demographic features of patients.
n

%

Female

156

30.6%

Male

354

69.4%

Sex

n

%

Hematochezia

146

28.6%

Stomachache

135

19.2%

Constipation

72

14.1%

Symptoms

Age, years
<40

22

4.3%

Weight loss

59

11.6%

40–49

44

8.6%

Diarrhea

46

9%

50–59

117

22.9%

Melena

17

3%

60–69

142

27.8%

Drugs used by patients

≥70

182

35.7%

ACE

74

14.5%

ARB

46

9%

Number of polyps
1

317

62.2%

ASA

50

9,8%

2

108

21.2%

Statin

31

6%

3

39

7.6%

Oral antidiabetics

32

6.2%

≥4

45

8.8%

Size of polyps
<10 mm

330

64.7%

180

35.3%

Size of polyps
<10 mm

330

64.7%

≥10 mm

≥10 mm

180

35.3%

Comorbid diseases
DM

93

18.2%

Adenomatous change

293

33.7%

HT

153

30%

Tubular

154

17.7%

HL

103

20.2%

Tubulovillous

76

8.7%

Acromegaly

6

1.2%

Villous

12

1.3%

Smoking

134

26.3%

Adeno cancer

130

14.9%

Alcohol

52

10.2%

Hyperplasic

74

8.5 %

Cecum

31

3.6%

Ascending colon

81

9.4%

Hepatic flexure

37

4.3%

Transverse colon

126

14.6%

Splenic flexure

17

2%

Descending colon

115

13.3%

Sigmoid colon

115

13.3%

Rectum

274

31.6%

Pathology

Polyp location

prevalence of colorectal adenomas is 15%–30% (10,11).
With the introduction of high-quality basal colonoscopies,
which allow for a complete and meticulous inspection of
all colonic mucosa and a complete removal of all neoplastic
lesions, this rate has increased to 50% (12). The incidence
rate of metachronous polyps in follow-up colonoscopies
varies in accordance with the frequency of follow-up and
patient characteristics (12%–60%) (13). The number, size,
and pathologic features of polyps in the basal colonoscopy
are defined as the risk factors for polyp recurrence (14).
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Erlangen et al. reported that the parameters for the
risk of polyp recurrence are advanced histological type
(tubulovillous and villous), family history of colon cancer,
the presence of more than two polyps, and polyps larger
than 10 mm. In our study, surveillance colonoscopies
were performed in 190 (37%) patients, with 127 (66.8%)
patients showing recurrences. However, we were not
able to confirm the results of Erlanger et al. since 83.4%
of our cases had only one or two polyps. In addition, the
number of surveillance colonoscopies was lower than that
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Table 2. Features of patients with surveillance colonoscopy and recurrence of colorectal adenomatous polyps.
Surveillance colonoscopy,
n = 190 (%)

Recurrence of polyps,
n = 127 (%)

No recurrences of polyps,
n = 63 (%)

Female

65 (34.2)

43 (33.9)

22 (34.9)

Male

125 (65.8)

84 (66.1)

41 (65.1)

0.82

11 (5.8)

7 (5.5)

4 (6)

0.52

P

Sex

Age, years
<40
40–49

19 (10)

12 (9.4)

7 (11)

0.71

50–59

36 (18.9)

26 (20.5)

10 (15.8)

0.44

60–69

53 (27.9)

36 (28.3)

17 (26.9)

0.84

≥70

71 (37.4)

46 (36.2)

25 (39.6)

0.64

119 (62.1)

78 (61.3)

41 (65)

0.78

Number of polyps
1
2

41 (21.3)

27 (21.3)

14 (22.2)

0.78

3

13 (6.8)

8 (6.3)

5 (7.9)

0.44

≥4

17 (8.9)

13 (10.2)

4 (6.3)

0.30

<10 mm

97 (51.1)

62 (48.8)

35 (55.5)

≥10 mm

93 (48.9)

65 (51.2)

28 (44.4)

Cecum

8 (4.2)

1 (0.7)

7 (11.1)

Ascending colon

16 (8.2)

12 (9.4)

4 (6.3)

Hepatic flexure

6 (3.2)

4 (3.1)

2 (3.1)

Transvers colon

28 (14.7)

18 (14.1)

10 (15.8)

Splenic flexure

7 (3.7)

4 (3.1)

3 (4.7)

Descending colon

27 (14.2)

22 (17.3)

5 (7.9)

Sigmoid colon

49 (25.8)

48 (37.7)

1 (1)

Rectum

49 (25.8)

44 (34.6)

5 (7.9)

Left-sided polyp

132 (69.4)

95 (74.8)

37 (57.8)

Tubular

51 (26.8)

35 (27.5)

16 (25.3)

Tubulovillous

30 (22.6)

21 (16.5)

9 (14.3)

Villous

7 (3)

4 (3.1)

3 (4.7)

Hyperplasic

12 (6.3)

6 (4.7)

6 (9.5)

126 (66.3)

84 (66.1)

42 (66.6)

0.94

38 (20)

24 (18.9)

14 (22.2)

0.59

Size of polyp
0.83

Polyps location

0.024

Pathology

High-risk patients
Comorbid disease
DM
HT

49 (25.7)

33 (25.9)

16 (25.3)

0.55

HL

39 (20.5)

23 (18.1)

16 (25.3

0.24

Smoking

54 (28.4)

38 (29.9)

16 (25.3)

0.51

Alcohol

14 (7.4)

10 (7.8)

4 (6.3)

0.47

DM: Diabetes mellitus; HT: hypertension; HL: hyperlipidemia; ACE: angiotensin converting enzyme; ARB: angiotensin 2 receptor
blocker; ASA: acetylsalicylic acid.
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Table 3. Risk factors for recurrence of colon polyps.
Odds ratio

P

Sex (male/female)

1.01 (0.55–1.85)

Family history of malignity

0.46 (0.14–1.50)

0.16

Family history of colon malignity

1.09 (0.42-2.80)

0.52

Smoking

0.79 (0.40–1.57)

0.51

Alcohol

0.79 (0.23–2.63)

0.47

DM

1.22 (0.58–2.57)

0.59

HL

1.53 (0.74–3.17)

0.24

Polyp number: 1–2/≥3

0.79 (0.34–1.84)

0.59

Polyp number: 1–3/≥4

1.1 (0.95–1.20)

0.12

Polyp size: <10 mm/≥10 mm

0.76 (0.41–1.40)

0.38

Histological type: Tubulovillous/villous

1.06 (0.47–2.39)

0.53

Left-sided colon polyps

2.08 (1.09–3.96)

0.02

Table 4. Risk factors for CRC.
Parameters

Odds ratio

1, 2–5, 6 or a higher polyp number

0.203

Polyp size (<10 mm, ≥10 mm)

13 (7.4–22.8)

0.0001

1, ≥2 polyps

1.6 (1.02–2.4)

0.01

Anemia

2.13 (1.4–3.1)

0.0001

ESR >25

2.6 (1.3–5.1)

0.03

CEA >4 ng/mL

1.9 (1.2–3.1)

0.006

CA19-9 >35 U/mL

1.0 (0.6–1.7)

0.91

Smoking

1.32 (0.8–2)

0.19

Alcohol consumption

0.62 (0.3–1.2)

0.18

DM

0.86 (0.5–1.46)

0.58

HL

0.87 (0.52–1.4)

0.59

Family history

0.75 (0.3–1.8)

0.54

Anemia and high rate of sedimentation

1.8 (1.1–2.4)

0.0001

found in the literature, which may be attributed to the fact
that patients may have not have attended their follow-up
examinations.
The baseline colonoscopy needs to be of high quality
for the baseline adenoma characteristics to be used for
planning surveillance intervals. The US Multi-Society Task
Force on Colorectal Cancer and the American Society
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P

for Gastrointestinal Endoscopy further extended the
recommended surveillance interval to 5–10 years for those
with 1 to 2 small (tubular) adenomas. In patients with 3
or more colorectal adenomas, regardless of size, a 3-year
surveillance interval is recommended (15). Several studies
have shown that compliance with guidelines remains poor.
The rate of first-year surveillance colonoscopy and polyp
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recurrence (40%) was higher in our study. This might be
explained by the fact that high-quality basal colonoscopy
could not be performed because the records of the patients
in the study were relatively old.
Sporadic colon cancers are mainly localized in the
right and left colon (29% in the rectum) in approximately
40% and 60% of all cases, respectively. According to the
literature published after 1980, there is increased evidence
of a shift towards the proximal colon. The localization of the
polyps in our study was similar to the literature; however,
left colon polyps (68.9%) and rectum polyps (31.6%) were
observed to be more common. The rate of right colon
polyps in our study (31.9%) was also lower than that in
the literature. This may be related to missing polyps in the
right colon due to inadequate cecal intubation rates and
noncompliance with the withdrawal time (16).
There was a significant correlation between patients
with left-sided colon polyps and polyp recurrence. This
can be explained in several ways: colonoscopists may pay
more attention to the sites where the excision of polyps
is performed and polyps may be incompletely removed,
suggesting that there may be missing colon polyps left
behind. The rate of missed colorectal polyps is 20% (17),
which can be linked to an inability to implement highquality colonoscopies.
In asymptomatic people, the prevalence of colorectal
adenomas increases with age, especially in patients over
the age of 50 (10,11). It has been discovered in autopsies
that the prevalence of colorectal adenomas is 50% at the
age of 70 (12). CRC and adenomas are observed two to
three times more frequently in males. Nusko et al. (18)
reported that 63.7% of patients with polyps were male.
Similar to these results, 67.8% of patients with polyps in
our study were male. In our study, the median age was 63
years old, and 82.5% of the cases were observed after the
fifth decade.
It has been found that the etiology of CRC and adenomas
involves environmental factors, especially dietary factors
(e.g., a fatty diet). It was proven by necropsy that there is a
relationship between CRC and HL. The production of bile
increases with a fatty diet and the increase of bile oxidation
leads to an increase in tumor activation (19). There was
HL in 20.2% of the patients in our study. However, the
correlation between the recurrence of polyps and HL was
not found to be significant. These findings may be related
to the fact that Turkey is a Mediterranean country and
our diets are different from those in western countries.
Moreover, in Turkey, the rate of bread consumption as
a source of fiber is more frequent than that reported in
western societies.

The relation between smoking and CRC risk has long
been known (20). The relationship between smoking and
CRC is more obvious in the long term. It has also been
found in previous studies that CRC is more commonly
observed in patients with DM (21). It was observed that
there was an increase in the recurrence rate of malignancy
in patients with insulin resistance. However, the conditions
mentioned above were not investigated in our study since
our study was retrospective, so we were not able to exactly
calculate how long patients had been exposed to smoking.
We also could not exactly determine whether or not these
patients had DM and if surveillance colonoscopy was
inadequate.
As polyps are generally asymptomatic, they can only be
diagnosed with screening. When polyps are symptomatic,
their diameter is generally greater than 10 mm and
rectal bleeding is the most common finding. In addition,
abdominal discomfort, change in bowel habits, and rectal
prolapses are other symptoms. GIS bleeding was similarly
found to be higher; however, interestingly, constipation
was found to be lower according to the literature data in
our study.
CRC was detected in 130 patients during the basal
colonoscopy in this study. We found a significant
correlation between CRC and the number of polyps (1,
≥2), size of the polyp (>10 mm), anemia, and high ESR and
CEA levels (25 and 4, respectively). For CRC screening,
older patients who have extreme anemia with a high ESR
should be taken into consideration. In the first surveillance
colonoscopy, 12 patients were diagnosed with CRC, and
these patients had advanced histological types in the basal
colonoscopy. Parameters such as a large number of polyps
(≥3) and advanced histologic type and size (≥10 mm) also
indicate a high risk for the development of CRC.
Aside from its retrospective nature, the major
limitations of our study were the relatively low number
of patients who had surveillance colonoscopy and an
intrinsic selection bias. Since the dysplasia grade of most
patients was missing, we could not evaluate this parameter
as a risk factor.
In conclusion, patients with left-sided colon polyps are
at risk for polyp recurrences. Furthermore, a significant
correlation was observed between the development of
CRC and advanced histological type, anemia with high
ESR, polyp size (<10 mm, ≥10 mm), and the number of
polyps (<3, ≥3). In our study, the rate of left-sided polyps
was found to be higher than that reported in the literature.
Flexible sigmoidoscopy is still important in Turkey during
the course of treatment. However, taken together with the
small number of cases included in this study, more studies
that include a larger number of patients are needed to
support our findings.
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